Medicine carbon footprinting across National Health Service trusts in England, 2021-2024: a longitudinal study using Freedom of Information requests
- 1YewMaker
Abstract
IntroductionMedicines account for 20% of the National Health Service (NHS) carbon footprint, but it is unclear how consistently they are measured by individual NHS trusts. This study assessed medicine carbon footprint (MCF) practices across NHS trusts in England and whether these changed between 2021 and 2024.
MethodsFreedom of Information requests were sent to NHS trusts about MCF practices in 2021 and 2024. Responses were analysed to determine the proportion of trusts calculating MCFs, the medicines included and the emission factors used for spend-based calculations. Reported spend-based factors were compared with the median factor for each year to assess the effect of factor choice on MCFs.
ResultsOf 196 trusts included in analysis, 178 (91%) responded for 2021 and 182 (93%) for 2024. Among responding trusts, 30 of 178 calculated MCFs in 2021 compared with 46 of 182 in 2024. Spend-based medicine footprinting increased from 19 trusts in 2021 to 31 in 2024. Ten different factors were used by 15 trusts in 2021 and 13 by 21 trusts in 2024. Reported factors ranged from 31% below to 258% above the median in 2024.
ConclusionsMedicine carbon footprinting remained uncommon, with only one-quarter of responding NHS trusts calculating a footprint in 2024. Among trusts using spend-based methods, wide variation in emission factors produced substantially different estimated MCFs. Clear national guidance on spend-based methodology could improve consistency in the short term, while greater use of standardised product-level approaches may better support medicine decarbonisation over time.
Related
- Adequacy of Clinical Information in Knee Radiography Requests With Reference to the Pittsburgh Knee Rule: A Single-Centre Clinical Audit.
- Theoretical Knowledge, Self-Assessed Competence, and Information-Seeking Behaviors in Evidence-Based Medicine Among Polish Medical Students: A Cross-Sectional Study
- Household energy, tuberculosis, and poverty: which national signals track the rising global burden of interstitial lung disease? A 204-country longitudinal study, 2000–2021, with projections to 2050
- Reproductive life course histories and menopausal outcomes at midlife: evidence from the National Longitudinal Study of Adolescent to Adult Health
- Trends in diversity of scientific authorship by ethnicity, sex and age of authors in a National Institute for Health and Care Research Biomedical Research Centre in England: a retrospective longitudinal bibliometric study.
BibTeX
@misc{taylor2026medicine,
title = {{Medicine carbon footprinting across National Health Service trusts in England, 2021-2024: a longitudinal study using Freedom of Information requests}},
author = {H. Taylor and N. Rahman},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.09.26365120},
url = {https://www.medrxiv.org/content/10.64898/2026.10.09.26365120v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - Medicine carbon footprinting across National Health Service trusts in England, 2021-2024: a longitudinal study using Freedom of Information requests
AU - H. Taylor
AU - N. Rahman
PY - 2026
DA - 2026/10/09
PB - medRxiv
DO - 10.64898/2026.10.09.26365120
UR - https://www.medrxiv.org/content/10.64898/2026.10.09.26365120v1
AB - IntroductionMedicines account for 20% of the National Health Service (NHS) carbon footprint, but it is unclear how consistently they are measured by individual NHS trusts. This study assessed medicine carbon footprint (MCF) practices across NHS trusts in England and whether these changed between 2021 and 2024. MethodsFreedom of Information requests were sent to NHS trusts about MCF practices in 2021 and 2024. Responses were analysed to determine the proportion of trusts calculating MCFs, the medicines included and the emission factors used for spend-based calculations. Reported spend-based factors were compared with the median factor for each year to assess the effect of factor choice on MCFs. ResultsOf 196 trusts included in analysis, 178 (91%) responded for 2021 and 182 (93%) for 2024. Among responding trusts, 30 of 178 calculated MCFs in 2021 compared with 46 of 182 in 2024. Spend-based medicine footprinting increased from 19 trusts in 2021 to 31 in 2024. Ten different factors were used by 15 trusts in 2021 and 13 by 21 trusts in 2024. Reported factors ranged from 31% below to 258% above the median in 2024. ConclusionsMedicine carbon footprinting remained uncommon, with only one-quarter of responding NHS trusts calculating a footprint in 2024. Among trusts using spend-based methods, wide variation in emission factors produced substantially different estimated MCFs. Clear national guidance on spend-based methodology could improve consistency in the short term, while greater use of standardised product-level approaches may better support medicine decarbonisation over time.
ER -